Table 3. Baseline characteristics of treated patients with isolated ICA occlusion and ICA-MCA tandem occlusion.

Characteristics	Isolated ICA occlusion IVT (n = 10)	Isolated ICA occlusion IVT/EVT (n = 12)	P Value	ICA-MCA Occlusion IVT (n = 13)	ICA-MCA Occlusion IVT/EVT (n = 16)	P Value
Male sex	5 (50%)	8 (67%)	0.666	5 (39%)	7 (44%)	1.000
Median age (y)	76 (70–84)	64 (57–76)	0.111	86 (76–91)	72 (57–77)	0.004
Median NIHSS Score	13 (8–18)	12 (5–17)	0.792	17 (15–19)	15 (11–17)	0.17
Arterial hypertension	10 (100%)	9 (75%)	0.221	11 (85%)	12 (75%)	0.663
Diabetes mellitus	2 (20%)	3 (25%)	1.0	1 (8%)	1 (6%)	1.0
Atrial fibrillation	4 (40%)	3 (25%)	0.652	9 (69%)	5 (31%)	0.066
Hyperlipidemia	5 (50%)	7 (58%)	1.0	8 (61%)	8 (50%)	0.711
Smoking	1 (10%)	4 (33%)	0.323	2 (15%)	3 (19%)	1.000
Previous stroke	3 (30%)	2 (17%)	0.624	3 (23%)	0 (0%)	0.078
Coronary heart disease	1 (10%)	1 (8%)	1.0	4 (31%)	1 (6%)	0.144
Site of MCA occlusion
M1 (main stem)	0	0	-	9(69%)	8(50%)	0.451
M2/M3	2 (20%)	2 (17%)	1.0	0	0	-
Carotid T	0	0	-	4 (31%)	8(50%)	0.451
Median onset to IV rTPA (min)	88 (74–236)	80 (64–149)	0.390	115 (96–129),	89 (47–144)	0.255
Median onset to endovascular treatment (min)	Not applicable	162 (128–264)	-	Not applicable	177 (125–250)	-